Martin Feuring

5.3k total citations · 2 hit papers
82 papers, 4.1k citations indexed

About

Martin Feuring is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Martin Feuring has authored 82 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 36 papers in Internal Medicine and 17 papers in Surgery. Recurrent topics in Martin Feuring's work include Venous Thromboembolism Diagnosis and Management (36 papers), Atrial Fibrillation Management and Outcomes (32 papers) and Hormonal Regulation and Hypertension (12 papers). Martin Feuring is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (36 papers), Atrial Fibrillation Management and Outcomes (32 papers) and Hormonal Regulation and Hypertension (12 papers). Martin Feuring collaborates with scholars based in Germany, United States and Sweden. Martin Feuring's co-authors include Martin Wehling, Elisabeth Falkenstein, Joachim Stangier, Michael Christ, Hanns-Christian Tillmann, Andreas Clemens, Joanne van Ryn, Sebastian Haertter, Karl‐Heinz Liesenfeld and Wolfgang Wienen and has published in prestigious journals such as Circulation, Physiological Reviews and Blood.

In The Last Decade

Martin Feuring

82 papers receiving 3.9k citations

Hit Papers

Dabigatran etexilate – a novel, reversible, oral dire... 2000 2026 2008 2017 2010 2000 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
    2010 1.0k citations Joachim Stangier, Sebastian Haertter et al. profile →
  2. Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
    2000 771 citations Elisabeth Falkenstein, Michael Christ et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Feuring Germany 26 1.8k 1.4k 870 705 657 82 4.1k
Mariella Trovati Italy 37 1.4k 0.7× 129 0.1× 1.8k 2.1× 873 1.2× 650 1.0× 132 4.4k
Giovanni Anfossi Italy 35 1.3k 0.7× 126 0.1× 1.3k 1.5× 957 1.4× 444 0.7× 122 4.0k
Yue Qi China 39 1.2k 0.7× 68 0.1× 750 0.9× 871 1.2× 794 1.2× 194 4.8k
Barbara T. Alexander United States 44 2.0k 1.1× 127 0.1× 585 0.7× 741 1.1× 996 1.5× 121 7.0k
Kyosuke Takeshita Japan 35 981 0.5× 93 0.1× 290 0.3× 1.7k 2.5× 517 0.8× 141 4.4k
Ludwig Neyses United Kingdom 51 2.6k 1.5× 141 0.1× 810 0.9× 3.4k 4.9× 809 1.2× 190 6.8k
Katsusuke Yano Japan 34 2.9k 1.6× 194 0.1× 430 0.5× 1.2k 1.7× 600 0.9× 179 4.2k
P Vague France 35 629 0.3× 84 0.1× 1.8k 2.0× 736 1.0× 1.2k 1.8× 95 4.3k
Masashi Akaike Japan 35 1.3k 0.7× 51 0.0× 604 0.7× 1.3k 1.9× 820 1.2× 116 4.4k
M. McLaren United Kingdom 30 479 0.3× 85 0.1× 201 0.2× 695 1.0× 325 0.5× 95 2.6k

Countries citing papers authored by Martin Feuring

Since Specialization
Citations

This map shows the geographic impact of Martin Feuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Feuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Feuring more than expected).

Fields of papers citing papers by Martin Feuring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Feuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Feuring. The network helps show where Martin Feuring may publish in the future.

Co-authorship network of co-authors of Martin Feuring

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Feuring. A scholar is included among the top collaborators of Martin Feuring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Feuring. Martin Feuring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samama, Charles Marc, Nadia Rosencher, Eva Kleine, et al.. (2016). Observational study of dabigatran etexilate 150 mg in patients with moderate renal impairment undergoing elective total hip or knee replacement. Thrombosis Research. 143. 103–110. 4 indexed citations
2.
3.
Feuring, Martin & Joanne van Ryn. (2016). The discovery of dabigatran etexilate for the treatment of venous thrombosis. Expert Opinion on Drug Discovery. 11(7). 717–731. 6 indexed citations
4.
Goldhaber, Samuel Z., Ajay K. Kakkar, Sebastian Schellong, et al.. (2015). Abstract 12422: Influence of Polypharmacy on the Efficacy And Safety Of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER® and RE-COVER II™. Circulation. 1 indexed citations
5.
6.
Schulman, Sam, Henry Eriksson, Samuel Z. Goldhaber, et al.. (2014). Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II. Circulation. 130. 4 indexed citations
7.
Barsness, Gregory W., J. S. C. Smith, Bengt I. Eriksson, et al.. (2011). Abstract 14413: Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopedic Surgery. Circulation. 124. 2 indexed citations
8.
Feuring, Martin, Martin Wehling, & Armin Schultz. (2011). Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study. Clinical and Experimental Pharmacology and Physiology. 38(11). 783–786. 13 indexed citations
9.
Sullivan, Patrick W., et al.. (2011). PCV110 Health-Related Quality of Life After Venous Thromboembolism. Value in Health. 14(7). A384–A384. 1 indexed citations
10.
Huo, Michael H., Andreas Kurth, Ola E. Dahl, et al.. (2011). Oral Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty: A Pooled Analysis of Four Randomized Trials. Blood. 118(21). 2312–2312. 1 indexed citations
11.
Kellner, Markus, Mathias Hafner, Martin Feuring, et al.. (2003). Early aldosterone up-regulated genes: New pathways for renal disease?. Kidney International. 64(4). 1199–1207. 31 indexed citations
12.
Feuring, Martin, Thomas Bertsch, K Rossol-Haseroth, et al.. (2002). Seminal plasma hormone concentration after oral application of progesterone. International Journal of Clinical Pharmacology and Therapeutics. 40(2). 47–53. 2 indexed citations
13.
Lösel, Ralf, Martin Feuring, & Martin Wehling. (2002). Non-genomic aldosterone action: from the cell membrane to human physiology. The Journal of Steroid Biochemistry and Molecular Biology. 83(1-5). 167–171. 28 indexed citations
14.
Feuring, Martin, Wolfgang Timmer, Markus Neuhäuser, et al.. (2001). The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology. 108(4). 530–536. 57 indexed citations
15.
Feuring, Martin, et al.. (2001). [Drug therapy in the old age. Drug effects in the elderly].. PubMed. 143(51-52). 33–5. 1 indexed citations
16.
17.
Harenberg, Job, et al.. (2001). Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex. Journal of Laboratory and Clinical Medicine. 137(6). 408–413. 3 indexed citations
18.
Feuring, Martin, Martin Wehling, & Elisabeth Falkenstein. (2000). Beeinflussung der Arzneimittelwirkung durch Erbfaktoren und Erkrankungen. Der Internist. 41(4). 332–337. 1 indexed citations
19.
Schmidt, Bernhard M. W., Dirk Gerdes, Martin Feuring, et al.. (2000). Rapid, Nongenomic Steroid Actions: A New Age?. Frontiers in Neuroendocrinology. 21(1). 57–94. 134 indexed citations
20.
Falkenstein, Elisabeth, Michael Christ, Martin Feuring, & Martin Wehling. (2000). Specific nongenomic actions of aldosterone. Kidney International. 57(4). 1390–1394. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariella Trovati Breakdown of academic impact, for papers by Giovanni Anfossi Breakdown of academic impact, for papers by Yue Qi Breakdown of academic impact, for papers by Barbara T. Alexander Breakdown of academic impact, for papers by Kyosuke Takeshita Breakdown of academic impact, for papers by Ludwig Neyses Breakdown of academic impact, for papers by Katsusuke Yano Breakdown of academic impact, for papers by P Vague Breakdown of academic impact, for papers by Masashi Akaike Breakdown of academic impact, for papers by M. McLaren
Rankless by CCL
2026